Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus

Aim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coa...

Full description

Bibliographic Details
Main Authors: Dmitriy Sergeevich Atarshchikov, Vladimir Yur'evich Evgrafov, Yury Evgen'evich Batmanov
Format: Article
Language:English
Published: Endocrinology Research Centre 2010-03-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/6025
_version_ 1797255270367232000
author Dmitriy Sergeevich Atarshchikov
Vladimir Yur'evich Evgrafov
Yury Evgen'evich Batmanov
author_facet Dmitriy Sergeevich Atarshchikov
Vladimir Yur'evich Evgrafov
Yury Evgen'evich Batmanov
author_sort Dmitriy Sergeevich Atarshchikov
collection DOAJ
description Aim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coagulation after subtenon administrationof triamcinolone (40 mg) under ultrasonic control. Results. PLC at the stage of severe non-proliferative DR stabilized its development in 35% of the patients and caused its reverse development withresolution of oedema and intraretinal hemorrhage, normalization of vein diameter, and improvement of visual acuity in 30%. In 35% of these casesPLC caused neovascularization within 1.6?0.9 years after treatment. Reverse development of DR after PLC was documented in 46.3% cases withearly proliferative DR but stabilization of DR occurred rarer than in the previous group (14.6%) and hemorrhage into the vitreous body more frequently(12 cases in 41 and 2 in 40 respectively, p = 0.0007). Patients with severe non-proliferative DR tended to have reduced requirement for vitrectomyafter PLC compared with those having early proliferative DR (1 case of 40 and 6 of 41, p = 0.052).Conclusion: The above results suggest the necessity of early PLC in DM1 patients.
first_indexed 2024-03-08T15:22:11Z
format Article
id doaj.art-45340d6bf79e49b5b1900d5b2ff1185a
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:03:11Z
publishDate 2010-03-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-45340d6bf79e49b5b1900d5b2ff1185a2024-03-20T11:47:55ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782010-03-0113111211510.14341/2072-0351-60255983Results of early panretinal laser coagulation in patients with type 1 diabetes mellitusDmitriy Sergeevich Atarshchikov0Vladimir Yur'evich Evgrafov1Yury Evgen'evich Batmanov2Endocrinological Research Centre, Moscow; Russian State Medical University, MoscowRussian State Medical University, MoscowRussian State Medical University, MoscowAim. To evaluate results of panretinal laser coagulation (PLC) for severe non-proliferative and early proliferetaive diabetic retinopathy (DR) in patientswith type 1 diabetes mellitus (DM1). Materials and methods. 58 patients with DM1 were observed. All of them were treated by panretinal laser coagulation after subtenon administrationof triamcinolone (40 mg) under ultrasonic control. Results. PLC at the stage of severe non-proliferative DR stabilized its development in 35% of the patients and caused its reverse development withresolution of oedema and intraretinal hemorrhage, normalization of vein diameter, and improvement of visual acuity in 30%. In 35% of these casesPLC caused neovascularization within 1.6?0.9 years after treatment. Reverse development of DR after PLC was documented in 46.3% cases withearly proliferative DR but stabilization of DR occurred rarer than in the previous group (14.6%) and hemorrhage into the vitreous body more frequently(12 cases in 41 and 2 in 40 respectively, p = 0.0007). Patients with severe non-proliferative DR tended to have reduced requirement for vitrectomyafter PLC compared with those having early proliferative DR (1 case of 40 and 6 of 41, p = 0.052).Conclusion: The above results suggest the necessity of early PLC in DM1 patients.https://www.dia-endojournals.ru/jour/article/view/6025diabetic retinopathypanretinal laser coagulationtriamcinolonediabetes mellitus
spellingShingle Dmitriy Sergeevich Atarshchikov
Vladimir Yur'evich Evgrafov
Yury Evgen'evich Batmanov
Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
Сахарный диабет
diabetic retinopathy
panretinal laser coagulation
triamcinolone
diabetes mellitus
title Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_full Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_fullStr Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_full_unstemmed Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_short Results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
title_sort results of early panretinal laser coagulation in patients with type 1 diabetes mellitus
topic diabetic retinopathy
panretinal laser coagulation
triamcinolone
diabetes mellitus
url https://www.dia-endojournals.ru/jour/article/view/6025
work_keys_str_mv AT dmitriysergeevichatarshchikov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus
AT vladimiryurevichevgrafov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus
AT yuryevgenevichbatmanov resultsofearlypanretinallasercoagulationinpatientswithtype1diabetesmellitus